Skip to main content

Table 3 Hospital outcomes (N = 9)

From: Combination therapy with erythropoietin, magnesium sulfate and hypothermia for hypoxic-ischemic encephalopathy: an open-label pilot study to assess the safety and feasibility

 

Median (range) or N (%)

In-hospital death

0 (0)

Established oral feeding at discharge

8 (89)

Mechanical ventilation at discharge

1 (11)

Normal brain MRI findings

7 (78)

Hospital stay, days

18 (16, 81)